The likelihood that a person with early-stage non-small cell lung cancer will receive curative treatment still varies considerably by race, even though 3 decades have passed since researchers first ...

TRIANA Biomedicines Announces First Patient Dosed in a Phase 1/2 Trial Evaluating TRI-611 for the Treatment of ALK+ Non-small Cell Lung Cancer ...

bioAffinity Technologies Inc. BIAF shares are down during Thursday’s premarket session. Over the last week, the stock has ...

The researchers found higher ATF4 levels in tumors from older subjects, both in mice and in human patients. Elevated ATF4 was also linked to a greater chance of cancer returning after lung surgery and ...

Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have ...

We are curing more cancers than we used to,” Cottrill said. “Recurrent cancers are more challenging to cure than cancers that ...

Severe COVID-19 may raise lung cancer risk by creating a tumour-promoting lung environment after viral pneumonia, new research suggests.

Individuals who have contracted Covid could be at an increased risk of developing a certain type of cancer, as per a recent study. The research indicates that those who suffered from severe Covid-19 ...

Severe forms of COVID-19 or influenza can trigger the development of lung cancer years after recovery. This was reported on ...

Racura Oncology’s lead drug candidate RC220 has cleared an important regulatory hurdle after receiving governance approval from Monash Health to start a phase I clinical trial in patients with ...

Respiratory illnesses such as COVID-19 and influenza are usually thought of as short-term infections that cause fever, cough, and fatigue. Most people recover within days or weeks. However, scientists ...